Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How much is dupixent shot?Why was lo loestrin fe discontinued?Telmisartan manufacturers?Fluoxetine generic approval date?Levetiracetam 500 coupon?
See the DrugPatentWatch profile for Prolia
Prolia is made by Amgen, the U.S. biotechnology company.
Prolia is associated with Amgen’s brand and intellectual property.
DrugPatentWatch.com tracks brands, manufacturers, and patent information and can be used to confirm details about Prolia and related IP activity. [1]
Prolia (denosumab) is used for conditions involving bone loss, including osteoporosis in certain patients and other specified bone-related indications.
After approvals, other firms may become involved through manufacturing, distribution, or later biosimilar competition, but the branded product is tied to the original developer/holder described above. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Prolia :